This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a chiral building block in the production of enantiomerically pure drugs, which are critical for ensuring the desired biological activity and minimizing side effects. Its structure, featuring a methylsulfonyl group and an amine moiety, makes it valuable in the design of compounds targeting neurological and psychiatric disorders, such as depression, anxiety, or schizophrenia. Additionally, it is employed in medicinal chemistry for the optimization of drug candidates, enhancing their pharmacokinetic and pharmacodynamic properties. Its role in the development of selective serotonin reuptake inhibitors (SSRIs) and other CNS-targeting therapeutics highlights its significance in advancing treatments for mental health conditions.